Mark H. Ravich - 17 Jun 2021 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Role: Director
Signature: /s/ Michael G. Costello, Attorney-in-Fact for Mark H. Ravich
Issuer symbol: RMTI
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 22 Jun 2021, 17:27:40 UTC
Next filing: 09 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMTI	Common Stock	Award	$0	+50,000	+25%	$0.000000	253,604	17 Jun 2021	Direct	F1
holding	RMTI	Common Stock						16,000	17 Jun 2021	By: Alyssa Danielle Ravich 1991 Irrevocable Trust	F2
holding	RMTI	Common Stock						9,000	17 Jun 2021	By: Alexander Coleman Ravich 1991 Irrevocable Trust	F3
holding	RMTI	Common Stock						219,905	17 Jun 2021	BY: Revocable Trust of Mark H Ravich	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RMTI	Stock Option (Right to Buy)	Award	$0	+72,857		$0.000000	72,857	17 Jun 2021	Common Stock	72,857	$0.9000	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer.
F2	Represents securities owned directly by Alyssa Danielle Ravich 1991 Irrevocable Trust ("ADR Trust"). Mr. Ravich, as the trustee of ADR Trust, may be deemed to beneficially own the securities owned directly by ADR Trust.
F3	Represents securities owned directly by Alexander Coleman Ravich 1991 Irrevocable Trust ("ACR Trust"). Mr. Ravich, as the trustee of ACR Trust, may be deemed to beneficially own the securities owned directly by ACR Trust.
F4	Represents securities owned directly by Revocable Trust of Mark H Ravich ("MHR Trust"). Mr. Ravich, as the trustee of MHR Trust, may be deemed to beneficially own the securities owned directly by MHR Trust.
F5	Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer.